Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2364735
Max Phase: Preclinical
Molecular Formula: C10H12N5Na4O13P3
Molecular Weight: 507.18
Molecule Type: Small molecule
Associated Items:
ID: ALA2364735
Max Phase: Preclinical
Molecular Formula: C10H12N5Na4O13P3
Molecular Weight: 507.18
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C10H16N5O13P3.4Na/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;;/q;4*+1/p-4/t4-,6-,7-,10-;;;;/m1..../s1
Standard InChI Key: PZFIDIJKTNDKOV-KWIZKVQNSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 507.18 | Molecular Weight (Monoisotopic): 506.9957 | AlogP: -1.63 | #Rotatable Bonds: 8 |
Polar Surface Area: 279.13 | Molecular Species: ACID | HBA: 14 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: 4.92 | CX LogP: -5.36 | CX LogD: -10.47 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.20 | Np Likeness Score: 1.34 |
1. Nahum V, Zündorf G, Lévesque SA, Beaudoin AR, Reiser G, Fischer B.. (2002) Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists., 45 (24): [PMID:12431066] [10.1021/jm020251d] |
Source(1):